Henry M Kuerer Selected Research

Pathologic Complete Response

1/2021	Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by an intelligent vacuum-assisted biopsy.
12/2020	Accuracy of Post-Neoadjuvant Chemotherapy Image-Guided Breast Biopsy to Predict Residual Cancer.
10/2019	Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy.
12/2018	Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy.
7/2018	Biopsy Feasibility Trial for Breast Cancer Pathologic Complete Response Detection after Neoadjuvant Chemotherapy: Imaging Assessment and Correlation Endpoints.
10/2017	Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical Trials.
1/2017	Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery.
10/2016	Breast Cancer Clinical Trials: Past Half Century Moving Forward Advancing Patient Outcomes.
4/2016	Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy.
3/2016	Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henry M Kuerer Research Topics

Disease

170	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2002
97	Neoplasms (Cancer) 10/2021 - 01/2002
35	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 10/2003
34	Neoplasm Metastasis (Metastasis) 01/2020 - 05/2002
19	Pathologic Complete Response 01/2021 - 08/2005
8	Necrosis 03/2017 - 05/2004
7	Residual Neoplasm 01/2021 - 04/2004
7	Carcinoma (Carcinomatosis) 03/2016 - 05/2002
6	Inflammatory Breast Neoplasms 11/2020 - 07/2007
4	Disease Progression 10/2021 - 06/2006
3	Postoperative Pain 03/2020 - 09/2009
3	Margins of Excision 12/2019 - 02/2003
3	Lymphedema (Milroy Disease) 01/2019 - 10/2006
3	Triple Negative Breast Neoplasms 12/2018 - 01/2017
3	Lymphatic Metastasis 01/2017 - 06/2010
3	Lobular Carcinoma 09/2012 - 10/2006
3	Unilateral Breast Neoplasms 03/2011 - 01/2005
3	Wounds and Injuries (Trauma) 01/2010 - 02/2002
3	Ductal Carcinoma 10/2007 - 10/2006
2	Pain (Aches) 03/2020 - 11/2009
2	Circulating Neoplastic Cells 01/2020 - 11/2015
2	Ovarian Neoplasms (Ovarian Cancer) 01/2015 - 10/2014
2	Infections 08/2014 - 10/2004
2	Extranodal Extension 01/2012 - 06/2005
2	Seroma 01/2011 - 05/2004
2	Carcinogenesis 01/2009 - 11/2004
2	Congenital Abnormalities (Deformity) 12/2008 - 01/2006
2	Edema (Dropsy) 08/2005 - 07/2002
2	Hypotension (Low Blood Pressure) 08/2005 - 08/2004
2	Anaphylaxis (Anaphylactic Shock) 08/2005 - 02/2004
1	Neoplasm Micrometastasis 01/2018
1	Cellulitis 10/2017
1	Calcinosis 02/2016
1	Overweight 06/2012
1	Obesity 06/2012
1	Breast Diseases (Breast Disease) 05/2012
1	Lymphadenopathy 04/2011

Drug/Important Bio-Agent (IBA)

22	Estrogen ReceptorsIBA 03/2017 - 08/2004
14	Biological ProductsIBA 02/2016 - 09/2004
11	Hormones (Hormone)IBA 12/2020 - 11/2002
10	Progesterone Receptors (Progesterone Receptor)IBA 03/2017 - 04/2002
8	Proteins (Proteins, Gene)FDA Link 03/2006 - 12/2002
7	Tamoxifen FDA LinkGeneric 11/2021 - 01/2002
7	AnthracyclinesIBA 05/2012 - 06/2002
7	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2007 - 04/2002
6	Trastuzumab (Herceptin)FDA Link 03/2016 - 01/2007
6	Biomarkers (Surrogate Marker)IBA 05/2011 - 06/2002
5	ErbB Receptors (EGF Receptor)IBA 10/2019 - 08/2005
5	Paclitaxel (Taxol)FDA LinkGeneric 05/2012 - 04/2002
5	Fluorouracil (Carac)FDA LinkGeneric 07/2007 - 06/2002
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2007 - 06/2002
4	human ERBB2 proteinIBA 11/2020 - 03/2011
4	Estrogens (Estrogen)FDA Link 01/2012 - 04/2002
4	iso-sulfan blue (Lymphazurin)FDA LinkGeneric 08/2005 - 01/2003
2	Opioid Analgesics (Opioids)IBA 03/2020 - 06/2019
2	Phenobarbital (Luminal)FDA Link 03/2017 - 12/2010
2	PlasticsIBA 02/2016 - 05/2002
2	Dihydrotachysterol (AT 10)IBA 01/2016 - 10/2005
2	4-azidobenzylcarazolol (pABC)IBA 01/2010 - 01/2002
2	Monoclonal AntibodiesIBA 01/2007 - 02/2003
2	Coloring Agents (Dyes)IBA 08/2005 - 02/2004
2	Technetium Tc 99m Sulfur Colloid FDA Link 01/2005 - 11/2004
2	Peptides (Polypeptides)IBA 06/2004 - 05/2002
2	VaccinesIBA 08/2003 - 05/2002
1	Protons (Proton)IBA 05/2016
1	Tumor Biomarkers (Tumor Markers)IBA 10/2014
1	Indicators and Reagents (Reagents)IBA 07/2014
1	Biocompatible Materials (Biomaterials)IBA 09/2013
1	Docetaxel (Taxotere)FDA Link 05/2012
1	Carboplatin (JM8)FDA LinkGeneric 05/2012
1	DNA (Deoxyribonucleic Acid)IBA 03/2011
1	taxaneIBA 04/2010
1	Keratins (Keratin)IBA 04/2009

Therapy/Procedure

64	Neoadjuvant Therapy 01/2022 - 01/2002
60	Therapeutics 10/2021 - 02/2002
46	Radiotherapy 01/2022 - 04/2002
43	Mastectomy (Mammectomy) 01/2022 - 01/2002
42	Segmental Mastectomy (Lumpectomy) 01/2022 - 04/2002
38	Drug Therapy (Chemotherapy) 10/2021 - 01/2002
24	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 01/2003
14	Mammaplasty (Breast Reconstruction) 12/2019 - 05/2002
9	Prophylactic Mastectomy 01/2018 - 10/2006
5	Surgical Instruments (Clip) 01/2019 - 08/2014
5	Adjuvant Chemotherapy 01/2019 - 07/2002
5	Simple Mastectomy 02/2016 - 03/2004
4	Aftercare (After-Treatment) 01/2020 - 11/2002
3	Operative Surgical Procedures 10/2016 - 03/2003
3	Catheters 08/2014 - 02/2004
2	Modified Radical Mastectomy (Mastectomy, Modified) 11/2020 - 05/2002
2	Hepatectomy 01/2020 - 05/2012
2	Tissue Expansion Devices (Tissue Expander) 10/2017 - 06/2011
2	Salvage Therapy 10/2013 - 11/2002
2	Adjuvant Radiotherapy 10/2012 - 08/2004
2	Conduction Anesthesia (Regional Anesthesia) 11/2009 - 09/2009
2	Contraindications 04/2007 - 01/2006
2	Chemoprevention 01/2006 - 11/2002
1	Re-Irradiation 01/2020
1	Thoracotomy 03/2015
1	Metastasectomy 05/2012
1	General Anesthesia 11/2009